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Abstract
BACKGROUND: Increased incidence of pediatric end-stage renal disease (ESRD) with associated serious 
consequences indicating a major public health problem. Malnutrition and uremic wasting are leading causes of 
growth impairment and increasing morbidity and mortality of pediatric ESRD patients, predominantly those on regular 
hemodialysis (HD). Ghrelin and obestatin, which are known appetite regulatory hormones, might have a pivotal role 
in uremic wasting and growth impairment in hemodialyzed children.
AIM: The aim of the present study was to measure serum unacylated ghrelin (UAG) and obestatin and to investigate 
their roles in the growth impairment of Egyptian hemodialyzed children.
SUBJECTS AND METHODS: The study included 50 hemodialyzed and 40 healthy children recruited from the 
Department of Nephrology, Pediatric Hospital, Ain Shams University. Full clinical examination and measurement of 
anthropometric indices were done. Routine labs were done as well, with an assessment of serum levels of obestatin, 
UAG, and insulin by enzyme linked immunosorbent assay. Furthermore, we determined fasting serum glucose and 
lipid profile with the calculation of homeostasis model assessment for insulin resistance (HOMA-IR).
RESULTS: Anthropometric measurements were statistically significantly decreased in the hemodialyzed group than 
that of the control group (p < 0.05). Weight z-score was the most affected anthropometric parameter (37 patients = 
74% with underweight and 13 patients = 26% with normal weight). The hemodialyzed children showed a significant 
increase of UAG, obestatin, insulin, glucose, HOMA-IR, and TG, while a significant decrease of HDL-cholesterol and 
albumin (p < 0.01). UAG had a negative correlation with Wt-z score, Ht z-score, fat mass %, albumin, and TG while 
obestatin was inversely correlated to Wt-z score, BMI z-score, waist circumference, and waist-height ratio (W/H).
CONCLUSION: UAG and obestatin hormones were elevated in a group of Egyptian children on regular HD. These 
hormones were strongly related to the impairment of renal functions, and anthropometric parameters, dyslipidemia, 
hypoalbuminemia, and insulin resistance in these pediatric hemodialyzed patients.
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Introduction
Chronic kidney disease (CKD) in children is a 
serious public health problem [1]. The overall number of 
pediatric patients with end-stage renal disease (ESRD) 
needing renal replacement therapy has increased 
significantly [2].
Nutritional status is particularly important 
in children as it influences growth, sexual, and 
neurocognitive development. Its accurate and routine 
assessment is strongly recommended in pediatric 
patients undergoing regular hemodialysis (HD) [3].
Protein-energy wasting (PEW) and growth 
retardation are typical issues in pediatric CKD 
associated with lower quality of life and robustly predict 
morbidity and mortality [4], in particular, ESRD imposing 
maintenance dialysis treatment [5], [6], [7].
Malnutrition contends a pivotal role in the 
development of stunted growth, commonly observed in 
children with CKD. The pathophysiology of malnutrition 
and wasting in pediatric CKD is complex, multifaceted, 
and not yet fully established. Various factors are potentially 
elaborated, embracing; uremic toxins retention, metabolic 
acidosis, elevated circulating pro-inflammatory cytokines, 
insulin resistance, besides the occurrence of depression 
secondary to the disease per se [8], [9].
Negative energy balance is one of the virtually 
important interposed mechanisms of PEW, imposed 
by increasing energy expenditure and reduced food 
intake [10], [11]. That may be consequential to anorexia 
due to variable mechanisms, including nausea, early 
satiety due to delayed gastric emptying, altered food 
taste, and smell, in some patients, the need to drink 
plenty of fluid to keep up with high urine output. 
Perturbations in anorexigenic/orexigenic hormonal 
balance may be a pivotal key in the pathogenesis of 
PEW in children with CKD [5], [12].
Ghrelin and obestatin are appetite regulatory 
hormones, originated from the same ghrelin gene 
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(GHRL), and produced by the stomach [13]. Their 
potential roles in uremic PEW have been investigated in 
adults [14], [15], [16] and, to a lesser extent, in pediatric 
CKD [17], [18], [19], with contradictory issues.
Ghrelin is a 28-amino acid peptide hormone 
secreted primarily by the oxyntic cells of the stomach. 
It is principally metabolized and excreted through the 
kidneys. Ghrelin is known as one of the most important 
appetite-regulating hormones. Two major circulating 
ghrelin forms detected; acyl ghrelin (AG), the active 
form, with orexigenic effect and the unacylated ghrelin 
(UAG), the main circulating ghrelin form, representing 
>90%, which appears to have the ability of increasing 
energy expenditure by declining food intake through the 
hypothalamus [20].
Obestatin (ghrelin-associated peptide) produced 
by the stomach from the same ghrelin gene, also 
recognized to have a homologous anorexigenic effect, 
fullness sensation, as well as slowing peristalsis [21].
To our knowledge, up till now, no studies 
have been done assessing the role of the hormones 
regulating energy homeostasis in Egyptian children 
with CKD, so in this study, we aimed to measure serum 
levels of UAG and obestatin in a group of Egyptian 
children with CKD on regular HD and to investigate 
their association with the anthropometric parameters in 
these hemodialyzed children.
Patients and Methods
This cross-sectional case–control study had 
been conducted on fifty children with an age range 
between 5 and 16 years, suffering from chronic renal 
failure, of variable durations on regular HD therapy, 
they have been recruited from the Department of 
Nephrology, Pediatric Hospital, Ain Shams University. 
Forty age- and sex-matched healthy children had been 
included as a control group. Exclusion criteria were 
treatment with growth hormone and/or the presence 
of neurologic disability or syndromes affecting per 
se food intake, patients with severe conditions such 
as generalized inflammation or end-stage malignant 
diseases.
Full history had been taken from the 
parents, including the original renal disease, previous 
interventions for renal problems, concomitant 
medications, child’s previous growth and development, 
precise timing, and sequence of the physical 
milestones. Clinical examination and anthropometric 
indices have been evaluated. Height was measured 
by the Harpenden stadiometer in centimeters. Weight 
was recorded in kilograms using an electronic weight 
scale. Body mass index (BMI) had been calculated by 
weight in kg/(height in meters)2. Z scores of height for 
age, weight for age, and BMI were calculated using 
AnthroPlus Program for personal computers based on 
the WHO growth standards [22]. Waist circumference 
(at the smallest point between the rib cage and the 
iliac crest) has been measured in centimeters using a 
flexible inextensible tape, and then waist/height (WHR) 
had been calculated. Biceps, triceps, subscapular 
and suprailiac skinfold thicknesses were measured 
by Holtain skinfold calipers. The percentage of fat 
mass (FM %) was calculated according to the Siri 
equation [23]. The parents of all participating children 
signed a written informed consent before taking part in 
the study, after explanation of the study’s objectives.
About 3 ml of fasting 12 hours venous blood 
samples were withdrawn from all subjects, centrifuged 
at 3000 r.p.m. for 10 min and sera were separated then, 
stored at ‒20°C until laboratory analysis. Serum creatinine 
was determined also on Hitachi AutoAnalyzer, Hitachi 
736 (Roche Diagnostics GmbH, D-68298 Mannheim, 
USA) using colorimetric techniques. Serum albumin was 
determined using the bromocresol green method (Ortho-
clinical Diagnostics Inc., Rochester, NY, USA). Serum 
levels of obestatin and UAG were measured using 
a commercial enzyme-linked immunosorbent assay 
(ELISA) kit, produced by Glory Science Co., Ltd. 2400 
Veterans Blvd. Suite 16-101, Del Rio, TX 78840, USA. 
The detection range of the obestatin kit was 20 ng/L–
400 ng/L, catalog number #:17526. The detection 
range of the ghrelin kit was 3 pg/ml–200 pg/ml catalog 
number #: 95622. The serum concentration of insulin 
was quantitatively determined by ELISA kit produced 
by (Chemux Bioscience, Inc, USA), a commercial kit of 
insulin was processed according to the manufacturer’s 
instructions. The assay sensitivity was found to be 
2.0 µIU/ml. Fasting serum glucose, total cholesterol, 
and triglycerides (TG) were measured on BioSystems 
BTS-302 photometer by an enzymatic colorimetric 
method using the Bio-Diagnostic kit (Egypt) [24]. HDL-
cholesterol (HDL-C) was measured by the precipitation 
endpoint method, the supernatant was separated, and 
HDL-C was determined using the same method for total 
cholesterol described above. Serum LDL-cholesterol 
(LDL-C) levels were calculated using the Friedewald 
formula (LDL-C = Total cholesterol–HDL-C–[TG/5]) [25]. 
Insulin resistance was calculated by the homeostasis 
model assessment for insulin resistance (HOMA-IR) by 
the formula (fasting insulin [mIU/ml] × fasting glucose 
[mg/dl]/405). Considering insulin resistance if HOMA-IR 
index exceeding 3.16 [26].
Statistical analysis
Data were analyzed using IBM SPSS Statistics 
v. 22. Independent t-test was used for comparison 
between quantitative data of the two studied groups; 
normally distributed variables have been expressed as 
mean ± SD. The correlation between two quantitative 
parameters in the same group was assessed by 
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Pearson correlation analysis. Statistical significance 
was considered when p < 0.05.
Results
The current study included 50 hemodialyzed 
children and 40 age- and sex-matched healthy Egyptian 
children as a control group, their mean age was (12.8 
± 3.01 and 13.5 ± 2.6 years), respectively. According 
to primary renal disease, 12 (24%) patients had post 
renal cause, while 38 (76%) patients had intrinsic 
renal disease. Their anthropometric measurements 
as shown in Table 1 indicating statistically significant 
decrease in the hemodialyzed group than that of the 
control group (all p < 0.05), except for waist-height 
ratio.
Table 1: Comparison between cases and controls as regards 
anthropometric measures
Variables Hemodialyzed children
(n=50) Mean ± SD
Control
(n=40) Mean ± SD
p-value
Age (years) 12.8 ± 3.01 13.5 ± 2.6 0.306
Wt-z score ‒3.00 ± 1.72 0.05 ± 1.11 ˂0.001**
Ht z-score ‒2.87 ± 1.60 1.38 ± 0.42 ˂0.001**
BMI z-score ‒1.41 ± 1.25 1.38 ± 0.42 ˂0.001**
Waist circumference 62.78 ± 8.0 79.8 ± 11.10 0.003**
Waist-height ratio (W/H) 0.48 ± 0.07 0.45 ± 0.04 0.3 
Biceps-SFT (mm) 5.11 ± 1.61 8.42 ± 2.45 0.004**
Triceps-SFT(mm) 7.05 ± 2.20 10.10 ± 2.58 0.01*
Subscapular-SFT(mm) 6.38 ± 2.50 8.95 ± 2.78 0.02*
Suprailiac-SFT (mm) 5.68 ± 2.72 8.89 ± 2.95 0.005**
*(p≤0.05): Hemodialyzed cases significantly different from controls. **(p<0.01) Hemodialyzed cases highly 
significant difference from controls. SD: Standard deviation, Wt-z score: Weight for age z score, Ht z-score: 
Height for age z score, BMI: Body mass index, SF: Skinfold.
Biochemical features of the studied groups 
shown in Table 2 with a statistically significant increase 
of the levels of UAG, obestatin, insulin, glucose, 
HOMA-IR, and TG, while a significant decrease of 
HDL-C and albumin in the studied hemodialyzed 
children than that of the control group (p < 0.05).
Table 2: Comparison between cases and controls as regards 
biochemical features
Variables Hemodialyzed children
(n=50) Mean ± SD
Control
(n=40) Mean ± SD
p-value
Unacylated ghrelin (pg/ml) 111.45 ± 31.15 87.59 ± 28.47 0.002**
Obestatin (ng/L) 223.73 ± 88.72 145.31 ± 19.78 ˂0.001**
Insulin (µIU/ml) 22.45 ± 12.76 9.46 ± 12.56 ˂0.001**
Glucose (mg/dl) 112.99 ± 31.84 71.2 ± 12.85 ˂0.001**
HOMA-IR 6.08 ± 4.53 1.73 ± 2.39 ˂0.001**
Total cholesterol (mg/dl) 97.57 ± 47.47 95.00 ± 11.87 0.744
TG (mg/dl) 162.4 ± 74.54 86.6 ± 22.2 ˂0.001**
HDL-cholesterol (mg/dl) 53.91 ± 8.97 71.00 ± 22.2 ˂0.001**
LDL-cholesterol (mg/dl) 45.27 ± 36.1 38.27 ± 7.51 0.239
Albumin (g/dl) 3.28 ± 0.54 4.89 ± 0.9 0.03*
*(p≤0.05): Hemodialyzed cases significantly different from controls. **(p<0.01) Hemodialyzed cases highly 
significant difference from controls.
There were inverse statistically significant 
correlations between UAG with Wt-z score (Figure 1), 
Ht z-score and FM %, and also between obestatin with 
Wt-z score, BMI z-score (Figure 2), waist circumference, 
and waist-height ratio (W/H). A statistically significant 
negative correlation between UAG and albumin was 
detected. Both UAG and obestatin showed a statistically 
significant positive correlation with predialysis creatinine 
(Table 3).
Figure 1: Correlation between unacylated ghrelin and Wt-z score in 
hemodialyzed group
Discussion
The current study assessed the relationship 
between anthropometric parameters and serum levels of 
UAG and obestatin in a group of Egyptian children with 
ESRD on regular HD to investigate the association between 
these anorexigenic hormones with growth retardation and 
wasting of these pediatric hemodialyzed patients.
Figure 2: Correlation between obestatin and BMI z-score in 
hemodialyzed group
As regarding the anthropometric 
measurements, a statistically significant decline of all 
anthropometric indices was observed in hemodialyzed 
children when compared with their healthy pears,
Table 3: Correlations between serum unacylated ghrelin, 
obestatin, and other variables
Variables Unacylated ghrelin (pg/ml) Obestatin (ng/L)
r p r p
Wt-z score ‒0.343 0.03 (*) ‒0.434 0.005 (**)
Ht z-score ‒0.452 0.003 (**) ‒0.140 0.389
BMI z-score ‒0.008 0.959 ‒0.612 0.000 (**)
Waist circumference ‒0.053 0.746 ‒0.328 0.039 (*)
Waist-height ratio (W/H) 0.025 0.878 ‒0.456 0.003 (**)
Fat mass (FM %) ‒0.511 0.002 (*) ‒0.295 0.06
Creatinine 0.402 0.01 (*) 0.373 0.02 (*)
HOMA-IR ‒0.066 0.725 ‒0.110 0.554
Total cholesterol (mg/dl) 0.077 0.637 ‒0.005 0.975
TG (mg/dl) ‒0.335 0.035 (*) 0.002 0.989
HDL-cholesterol (mg/dl) ‒0.003 0.986 ‒0.023 0.890
LDL-cholesterol (mg/dl) ‒0.180 0.267 0.037 0.820
Albumin (g/dl) ‒0.462 0.03 (*) ‒0.136 0.354
**Correlation is significant at the 0.01 level (2-tailed). *Correlation is significant at the 0.05 level (2-tailed).
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except for waist-height ratio that showed an increase, 
the ratio might be influenced by a severe decline in 
the height parameter than waist circumference of the 
hemodialyzed group. Weight z-score was the most 
affected anthropometric parameter (37 patients = 
74% with underweight and 13 patients = 26% with 
normal weight). Many studies came in agreement 
with our global finding of impaired anthropometrics 
but with some differences about the details due to 
different CKD series, and age groups with different 
development stages. In the same context of our 
findings, receiving dialysis treatment was associated 
with being underweight [27]; similarly, underweight was 
predominant in the hemodialyzed group [19], while 
percentages of overweight increased in CKD with renal 
transplant (maybe a drug effect due to corticosteroids 
administration, besides, appetite recovery after renal 
transplant therapy) [27]. In the contrast, the height 
was the most affected anthropometric parameter than 
weight in some studies [28], [29], [30].
In the present study, obestatin and UAG were 
statistically significantly higher in hemodialyzed children 
than control (223.73 ± 88.72 vs. 145.31 ± 19.78, p ˂  0.001) 
and (111.45 ± 31.15 vs. 87.59 ± 28.47, p = 0.002), 
respectively. On the same context, Monzani et al. [19] who 
measured ghrelin (acylated and unacylated) and obestatin 
in 110 pediatric CKD (42 on conservative treatment, 20 
on HD, and 48 transplantation recipients) and 43 controls, 
recording elevated UAG and obestatin concentrations 
in uremic children, notably in hemodialyzed than non-
dialyzed CKD patients and controls. Furthermore, 
increased total ghrelin with alternated AG/total ghrelin 
ratio (denoting elevation of UAG) in patients with ESRD 
undergoing dialysis was previously reported in many 
studies [31], [32], [33], [34], [35].
Both UAG and obestatin hormones showed 
a statistically significant positive correlation with 
predialysis levels of serum creatinine in the present 
study, confirming preceding findings have been 
reported by many researchers, with a suggested trend 
to increase of these anorexigenic hormones with the 
progression of renal impairment [19], [31], [36], [37].
Some researchers suggested that elevated 
levels of anorexigenic hormones such as obestatin and 
UAG observed in children with CKD on HD could be 
part of a defensive strategy to prevent the accumulation 
of toxic metabolites, which are normally cleared 
through the kidneys [19], prolonged half-life due to 
reduced renal clearance of these hormones under 
uremic conditions [38]. In addition, alterations in the 
activity of the enzymes involved in ghrelin deacylation, 
as uremic dyslipidemia may impair their function [39]. It 
may be ascribed to the inflammatory and substandard 
nutritional status of uremic patients [35].
Some studies were controversial, by their 
revealed normal or even subnormal serum levels of 
ghrelin in CKD patients on dialysis [14], [15], a possible 
clarification for this controvert might be that only UAG 
levels were elevated in the CKD patients. For instance, 
Gupta et al. [37] measured serum levels of AG and 
UAG levels in 51 CKD and 15 hemodialyzed patients, 
then demonstrated increased UAG levels with declining 
estimated glomerular filtration rate, while serum levels 
of AG kept unchanged.
On the other side, the study of Mafra et al. [40] 
has revealed low levels of obestatin and high levels 
of des-AG in hemodialyzed patients. However, lean 
patients had elevated levels of obestatin and des-AG. 
Despite, obscured by the unchanged obestatin levels 
after a meal in patients on maintenance HD, the 
relationship between sense of fullness and obestatin 
detected by Beberashvili et al. [41] might stipulate 
obestatin to behave as an anorexigenic. Up till now, 
there is controversy about the level of obestatin and 
its potential role, as an anorexigenic hormone, in the 
regulation of appetite and long-term food intake besides, 
its influence on the nutritional status and anthropometry 
in the hemodialyzed population [21], [40], [41], [42].
Despite, the variability of obestatin and UAG 
levels in CKD [9], [19], [34], [43], it has been postulated 
that disparity of these appetite-regulating hormones 
might assist in the defective appetite and PEW in uremic 
patients [44], [45], by an anorexigenic effect [33], as a 
compensatory response reflecting imbalanced energy 
status [46].
The current study revealed statistically significant 
negative correlations between UAG with Wt-z score, Ht 
z-score, and FM %, also between obestatin with Wt-z 
score, BMI z-score, waist circumference, and waist-height 
ratio (W/H), so both anorexigenic hormones are found to 
be inversely related to the anthropometric indices, besides, 
the statistically significant inverse relationship between 
UAG and albumin in these uremic pediatric patients.
To some extent, the findings of previous 
researches came in accordance with our conclusion 
about the negative correlation between the ghrelin 
system and the anthropometric parameters in 
CKD patients [35], [47], and healthy children [48]. 
Similarly, the inverse correlations between obestatin, 
BMI (r = ‒0.40, p = 0.007), and waist circumference 
(r = ‒0.38, p = 0.024) reported by Mafra et al. [40].
Furthermore, Monzani et al. [19] gave 
accentual evidence concerning the negative correlation 
between obestatin, UAG, and the anthropometric 
parameters (negative association between UAG with 
weight-SDS and BMI-SDS, also between obestatin 
with weight-SDS). These results help them to consider 
the hormones of UAG and to less extent, obestatin 
as promising inverse biomarkers of nutritional state 
in pediatric CKD patients, while on the contrast of our 
findings, they did not detect any relations between 
these two hormones and waist circumference, waist-
height ratio, or serum albumin.
In another respect, the reported results of the 
studies done by Eftekhari et al. [18] and Monzani et al. [19] 
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had confirmed our findings concerning the negative 
correlation between UAG and FM %. They suspected 
UAG to be considered as a promising biomarker of 
muscle-wasting, known to be associated with deleterious 
long-term consequences in uremic subjects, even in 
conditions with normal BMI records [49].
In the present study, hypoalbuminemia (serum 
albumin <3.5 mg/dl) have been detected in CKD patients 
on HD. Serum albumin was considered as the most 
common nutritional marker in HD patients, strongly 
predicting mortality [50]. However, this was criticized by 
Stenvinkel et al. [51] due to its close link to other non-
nutritional factors, mostly infection and inflammation [52].
There are strong existed data regarding 
dyslipidemia as a common finding in CKD patients, 
particularly those on maintenance HD, and its 
contribution to the risk of the high prevalence of 
cardiovascular disorders in these patients [53], [54].
Principally, dyslipidemia of CKD incorporated 
increased TG and decreased HDL-C levels [55], [56], 
this came in agreement with our findings of statistically 
significant increase of TG levels while a significant 
decrease of HDL-cholesterol in the studied hemodialyzed 
children than that of the control group (p < 0.01), with a 
non-significant increase of total cholesterol and LDL-C 
in the hemodialyzed group. Furthermore, previous 
studies reported similar findings [57], [58].
In the current study, no correlations have 
been detected between measured obestatin or UAG 
hormones and any of the lipid profile parameters, except 
for, the statistically significant negative correlation 
found between UAG and TG in the hemodialyzed group 
(r = −0.335, p = 0.035), otherwise, Monzani et al. [19] 
reported a statistically significant positive correlation 
between obestatin and TG (r = 0.195, p = 0.02).
On the other hand, no correlations between 
ghrelin and lipid profile have been detected by 
some researchers [35], [47], [59]. Otherwise, some 
experimental studies supposed the ability of obestatin 
to reduce serum lipids through reduction of food intake 
and intestinal absorption of TG, besides stimulating 
leptin secretion and fatty acid uptake [60], [61], [62].
In the current study, HOMA-IR was statistically 
elevated in hemodialyzed patients with a non-
significant negative correlation with obestatin and 
UAG. Moreover, insulin resistance was found to be a 
common finding in patients on maintenance HD even 
without diabetes [41], [63], Barazzoni et al. [64], [65] 
reported a strong negative association between UAG 
and HOMA-IR in their studies. In addition, Cappellari 
et al. [66] suggested an improvement of insulin activity 
due to overexpression of UAG in obesity-induced 
insulin resistance through reducing reactive oxygen 
species and increasing autophagy, with concomitant 
improvement of tissue inflammation.
Despite, the strong positive association between 
UAG and obestatin detected by Monzani et al. [19] 
and previously by Mafra et al. [40] suggesting clear 
association of the two hormones with common post-
translation regulation and a strong appetite management 
mechanism. On the contrast, this strong association 
could not be validated by our results due to the positive 
correlation between the two hormones was statistically 
non-significant. Ongoing the relationship between 
UAG and obestatin and their effect on the nutritional 
status and growth of CKD patients, especially those 
on maintenance HD still under debate and need more 
research.
Conclusion
The present study detected elevated serum 
levels of UAG and obestatin in hemodialyzed children 
compared to controls. Both hormones were negatively 
related to the anthropometric parameters, suggesting 
their link to the nutritional and growth impairment of 
these growing patients.
Further studies are needed to detect the role 
of the appetite regulators in CKD patients and their 
link to nutritional and growth impairment. This may 
help to provide reliable innovatory biomarkers for the 
diagnostic and therapeutic presumption of nutritional 
and growth defects in pediatric patients with CKD.
We recommend regular assessment of 
anthropometric and biochemical nutritional parameters 
in pediatric CKD, especially those on HD with regular 
follow-up by specialized dietitians.
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